Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. Long Term Debt 2008–2025
Charles River Laboratories International, Inc. annual long term debt history from 2010 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Charles River Laboratories International, Inc. long term debt as of December 29, 2018: 1.61B, a 48.27% increase year-over-year.
- Charles River Laboratories International, Inc. long term debt for 2018 were 1.61B, a 48.27% increase from 2017.
- Charles River Laboratories International, Inc. long term debt for 2017 were 1.09B, a 7.99% decrease from 2016.
- Charles River Laboratories International, Inc. long term debt for 2016 were 1.18B, a 44.98% increase from 2015.
- Charles River Laboratories International, Inc. long term debt for 2015 were 814.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Charles River Laboratories International, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $1,611 |
| 2017 | $1,086 |
| 2016 | $1,181 |
| 2015 | $814 |
| 2014 | $717 |
| 2013 | $663 |
| 2012 | $666 |
| 2011 | $718 |
| 2010 | $701 |
Charles River Laboratories International, Inc. Long Term Debt — FAQ
Charles River Laboratories International, Inc. (CRL) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRL's long term debt history?
The chart and table above show Charles River Laboratories International, Inc.'s long term debt by year and by quarter, including the growth rate.